Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics

Camac Partners, LLC, affiliates of Concord Investment Partners Ltd., and Leonite Capital LLC (collectively with their affiliates, the “Investor Group” or “we”), who are collectively the largest external stockholder of Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), today issued the below statement recommending stockholders vote on the WHITE proxy card to remove the Company’s Board of Directors (the “Board”) at the upcoming Special Meeting of Stockholders (the “Special Meeting”) scheduled for Friday, December 9^th, 2022:

“It is extremely important that Pasithea stockholders vote their shares on the WHITE proxy card as soon as possible, no matter how many or few shares you own. The Special Meeting is just a few days away and we believe that recent concerning actions taken by Pasithea’s Board — including multiple dilutive acquisitions at stockholders’ expense — underscore why urgent change is needed in the boardroom. By removing the Company’s current directors, we believe Pasithea will finally be positioned to enhance its corporate governance, improve capital allocation and unlock significant value for all stockholders.

Protect the value of your investment TODAY and vote FOR all matters on the WHITE proxy card by telephone, over the Internet, or by signing, dating and returning your WHITE proxy card in the postage-paid envelope provided.”

VOTE THE WHITE PROXY CARD TODAY.

If you have any questions on how to vote your shares on the WHITE proxy card, please contact InvestorCom LLC by email at [e-mail] or by telephone at 203-972-9300.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221206006144/en/

at the time of publication of the news with a fall of -1,46 % to 0,995 on Nasdaq stock exchange (07. Dezember 2022, 21:31 Uhr).